|
1
|
Denholm JT, Behr MA, de Vries G, Anthony R, Robinson E, Backx M, Laurenson IF, Seagar AL, Modestil H, Trieu L, Meissner JS, Ling Ng DH, Tay JY, Lin HH, Lee R, Donnan EJ, Sintchenko V, Marais BJ. Developing best practice public health standards for whole genome sequencing of Mycobacterium tuberculosis. THE LANCET REGIONAL HEALTH. WESTERN PACIFIC 2024; 46:101014. [PMID: 38827932 PMCID: PMC11143450 DOI: 10.1016/j.lanwpc.2024.101014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/27/2023] [Accepted: 01/10/2024] [Indexed: 06/05/2024]
Affiliation(s)
- Justin T. Denholm
- Victorian Tuberculosis Program, Melbourne, Australia
- Department of Infectious Diseases at the Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Australia
| | | | - Gerard de Vries
- Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
| | - Richard Anthony
- Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
| | - Esther Robinson
- TB Unit and National Mycobacterial Reference Service, United Kingdom Health Security Agency, London, UK
| | - Matthijs Backx
- Department of Microbiology, University Hospital of Wales, Cardiff, UK
| | - Ian F. Laurenson
- Scottish Mycobacteria Reference Laboratory, Royal Infirmary of Edinburgh, Edinburgh, UK
| | - Amie-Louise Seagar
- Scottish Mycobacteria Reference Laboratory, Royal Infirmary of Edinburgh, Edinburgh, UK
| | - Herns Modestil
- New York City Department of Health and Mental Hygiene, New York, USA
| | - Lisa Trieu
- New York City Department of Health and Mental Hygiene, New York, USA
| | | | - Deborah Hee Ling Ng
- National Tuberculosis Programme, National Centre for Infectious Diseases, Singapore
| | - Jun Yang Tay
- National Tuberculosis Programme, National Centre for Infectious Diseases, Singapore
| | - Hsien-Ho Lin
- Institute of Epidemiology and Preventive Medicine, National Taiwan University College of Public Health, Taiwan
| | - Robyn Lee
- Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada
| | - Ellen J. Donnan
- New South Wales Tuberculosis Program, Health Protection New South Wales, Sydney, Australia
| | - Vitali Sintchenko
- NSW Mycobacterium Reference Laboratory, Institute of Clinical Pathology and Medical Research, NSW Health, Australia
- Sydney Infectious Diseases Institute (Sydney ID), The University of Sydney, Sydney, Australia
| | - Ben J. Marais
- Sydney Infectious Diseases Institute (Sydney ID), The University of Sydney, Sydney, Australia
| |
Collapse
|
|
2
|
Kizny Gordon A, Marais B, Walker TM, Sintchenko V. Clinical and public health utility of Mycobacterium tuberculosis whole genome sequencing. Int J Infect Dis 2021; 113 Suppl 1:S40-S42. [PMID: 33716192 DOI: 10.1016/j.ijid.2021.02.114] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2021] [Revised: 02/18/2021] [Accepted: 02/25/2021] [Indexed: 12/19/2022] Open
Abstract
The World Health Organization (WHO) estimates that around 10 million people develop tuberculosis (TB) every year, with 1.5 million deaths attributed to TB in 2019 (World Health Organization, 2020). The majority of the disease burden occurs in low-income countries, where access to diagnostics and tailored treatment remains problematic. The current COVID-19 pandemic further threatens to impact global TB control by diverting resources, reducing notifications and hence significantly increasing deaths attributable to TB (World Health Organization, 2020). Whole genome sequencing (WGS) is becoming increasingly accessible, and has particular value in the diagnosis and management of TB disease (Cabibbe et al., 2018; Meehan et al., 2019). Not only does it have the potential to give more rapid and complete information on drug-resistance, but the high discriminatory power it offers allows detection of clusters and transmission pathways, as well as likely contamination events, mixed infections and to differentiate between re-infection and relapse with much greater confidence than previous typing methods.
Collapse
Affiliation(s)
- Alice Kizny Gordon
- Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Western Sydney Local Health District, Sydney, New South Wales, Australia; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
| | - Ben Marais
- WHO Collaborating Centre for Tuberculosis, The University of Sydney, Sydney, New South Wales, Australia; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, New South Wales, Australia
| | - Timothy M Walker
- Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam
| | - Vitali Sintchenko
- Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Western Sydney Local Health District, Sydney, New South Wales, Australia; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia; WHO Collaborating Centre for Tuberculosis, The University of Sydney, Sydney, New South Wales, Australia; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, New South Wales, Australia
| |
Collapse
|